Novartis, Bristol Myers pause autoimmune CAR-T trials due to safety concerns - BioPharma Dive
Source:Biopharmadive.com
The deaths of three study participants led Novartis to halt development of rap-cel in multiple indications, while “transient” side effects led Bristol Myers to voluntarily pause its zola-cel program.
Related Articles
GameStop CEO Says eBay Shut Account After Buyout Funding Stunt - Bloomberg.com
GameStop Corp. Chief Executive Officer Ryan Cohen said his eBay Inc. account was suspended following …
Goldman’s Solomon Says Market Reaction to War Is ‘Benign’ So Far - Bloomberg.com
Goldman Sachs Group Inc. Chairman David Solomon said he’s been surprised by the “benign” reaction in …
Trader Joe's recalls over 36 million pounds of product after glass found in rice - NBC News
A recall of Trader Joe’s food products that may contain glass was significantly expanded on …
Private Credit’s Gate-Crashers Are Forcing Funds Into a Brutal Spot - Bloomberg
The world’s largest alternative asset managers are confronting a painful choice: Block investors who …